Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel with ADT for Rising PSA Prostate Cancer
NCT00514917Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jul 2007
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by Sanofi. Started Jul 2007; status: terminated.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00514917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514917.